This compound is a pyridazinecarboxylic acid derivative that serves as a pharmaceutical intermediate used in the manufacture of deucravacitinib.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Deucravacitinib
pharmaceutical raw material
3-Pyridazinecarboxylic acid, 6-chloro-4-[[2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl]amino]-
pharmaceutical intermediate
Lithium 4,6-Dichloropyridazine-3-carboxylate
pharmaceutical intermediate
Methyl 4,6-dichloropyridazine-3-carboxylate
pharmaceutical intermediate
(2-Amino-5-nitrophenyl)(2-chlorophenyl)methanone Phthalimido
pharmaceutical intermediate
(2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methanol hydrochloride
pharmaceutical intermediate
4-Amino-3-fluoropyridine
pharmaceutical intermediate
Py-MAA-Val-Cit-PAB-MMAE
pharmaceutical intermediate
6-(cyclopropanecarbonylamino)-4-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]pyridazine-3-carboxylic acid
KVBLKXICHZUDRD-UHFFFAOYSA-N
CN1C=NC(=N1)C2=C(C(=CC=C2)NC3=CC(=NN=C3C(=O)O)NC(=O)C4CC4)OC
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.